JP2022541545A5 - - Google Patents

Info

Publication number
JP2022541545A5
JP2022541545A5 JP2022503439A JP2022503439A JP2022541545A5 JP 2022541545 A5 JP2022541545 A5 JP 2022541545A5 JP 2022503439 A JP2022503439 A JP 2022503439A JP 2022503439 A JP2022503439 A JP 2022503439A JP 2022541545 A5 JP2022541545 A5 JP 2022541545A5
Authority
JP
Japan
Prior art keywords
compound according
nhc
following formula
polar
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022503439A
Other languages
English (en)
Japanese (ja)
Other versions
JP7695229B2 (ja
JP2022541545A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042788 external-priority patent/WO2021016191A1/en
Publication of JP2022541545A publication Critical patent/JP2022541545A/ja
Publication of JP2022541545A5 publication Critical patent/JP2022541545A5/ja
Priority to JP2025094850A priority Critical patent/JP2025131767A/ja
Application granted granted Critical
Publication of JP7695229B2 publication Critical patent/JP7695229B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022503439A 2019-07-19 2020-07-20 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法 Active JP7695229B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025094850A JP2025131767A (ja) 2019-07-19 2025-06-06 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962876467P 2019-07-19 2019-07-19
US62/876,467 2019-07-19
US201962952048P 2019-12-20 2019-12-20
US62/952,048 2019-12-20
PCT/US2020/042788 WO2021016191A1 (en) 2019-07-19 2020-07-20 C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025094850A Division JP2025131767A (ja) 2019-07-19 2025-06-06 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法

Publications (3)

Publication Number Publication Date
JP2022541545A JP2022541545A (ja) 2022-09-26
JP2022541545A5 true JP2022541545A5 (enExample) 2023-07-27
JP7695229B2 JP7695229B2 (ja) 2025-06-18

Family

ID=74192606

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022503439A Active JP7695229B2 (ja) 2019-07-19 2020-07-20 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法
JP2025094850A Pending JP2025131767A (ja) 2019-07-19 2025-06-06 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025094850A Pending JP2025131767A (ja) 2019-07-19 2025-06-06 C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法

Country Status (10)

Country Link
US (2) US12344631B2 (enExample)
EP (1) EP3999522B1 (enExample)
JP (2) JP7695229B2 (enExample)
KR (1) KR102891865B1 (enExample)
CN (2) CN120248001A (enExample)
AU (1) AU2020316351A1 (enExample)
CA (2) CA3144603C (enExample)
MX (2) MX2022000781A (enExample)
TW (1) TWI861163B (enExample)
WO (1) WO2021016191A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2703274T3 (es) 2008-04-18 2019-03-07 Reata Pharmaceuticals Inc Moduladores de la inflamación antioxidantes: derivados del ácido oleanólico con modificaciones amino y otras en C-17
EA201890767A1 (ru) 2015-09-23 2019-09-30 Рита Фармасьютикалз, Инк. C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
EP3810141A1 (en) 2018-06-20 2021-04-28 Reata Pharmaceuticals, Inc. Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
KR102891865B1 (ko) * 2019-07-19 2025-11-26 리아타 파마슈티컬즈, 아이엔씨. C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법
CN120349366A (zh) * 2025-03-07 2025-07-22 国科大杭州高等研究院 五环三萜类衍生物、制备方法及其医药用途

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395423A (en) 1978-10-10 1983-07-26 Sterling Drug Inc. Polycyclic cyanoketones
US5064823A (en) 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
DE19817262A1 (de) 1998-04-18 1999-10-21 Bayer Ag Neue 2-heterocyclisch substituierte Dihydropyrimidine
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US6369101B1 (en) 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
US6365768B1 (en) 1999-05-14 2002-04-02 Nereus Pharmaceuticals, Inc. Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators
US6649654B1 (en) 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
WO2002003996A1 (en) 2000-07-12 2002-01-17 RAJKUMAR, Sujatha Use of dammarane-type tritepenoid saporins
AU2001294959A1 (en) 2000-09-29 2002-04-08 Robert M. Carlson Triterpenes having antibacterial activity
US6951847B2 (en) 2000-09-29 2005-10-04 Regents Of The University Of Minnesota Methods of treating fungal infections using lupeol
JP2004509972A (ja) 2000-09-29 2004-04-02 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 酵母に対する殺真菌活性を有するトリテルペン
EP1395255A4 (en) 2000-11-28 2007-09-12 Univ Texas CDDO COMPOUNDS AND COMBINATION THERAPIES THEREOF
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
US7176237B2 (en) 2002-01-15 2007-02-13 The Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
MXPA04006953A (es) 2002-01-18 2005-06-20 Univ Minnesota Sales cuaternarias de triperpeno como surfactantes biologicamente activos.
AU2003303128A1 (en) 2002-05-13 2004-08-13 Trustees Of Dartmouth College Inhibitors and methods of use thereof
WO2005042002A2 (en) 2003-10-30 2005-05-12 Entelos, Inc. Treatment of rhematoid arthritis with flip antagonists
US8288439B2 (en) 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication
US20060258752A1 (en) 2004-02-12 2006-11-16 Vander Jagt David L Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
CA2579231C (en) 2004-09-07 2018-07-10 Pacific Arrow Limited Anti-tumor compounds with angeloyl groups
WO2007005879A2 (en) 2005-07-01 2007-01-11 The Johns Hopkins University Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
US20070232577A1 (en) 2006-03-23 2007-10-04 Advanced Life Sciences, Inc. Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
WO2007127791A2 (en) 2006-04-25 2007-11-08 The Administrators Of The Tulane Educational Fund New pharmacological method for treatment of neuropathic pain
EP2032594B1 (en) 2006-06-27 2015-09-23 Wellington Laboratories Inc. Glycyrrhetinic acid derivatives
WO2008016095A1 (en) 2006-08-02 2008-02-07 Santen Pharmaceutical Co., Ltd. PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
WO2008064133A1 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8299046B2 (en) 2006-11-17 2012-10-30 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
DK2653873T3 (da) 2007-02-08 2022-07-25 Biogen Ma Inc Sammensætninger og anvendelser til behandling af multipel sklerose
WO2008111497A1 (ja) 2007-03-08 2008-09-18 Santen Pharmaceutical Co., Ltd. トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
WO2008136838A1 (en) 2007-05-04 2008-11-13 Trustees Of Dartmouth College Novel amide derivatives of cddo and methods of use thereof
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
US20090048205A1 (en) 2007-08-15 2009-02-19 Colin Meyer Combination therapy with synthetic triterpenoids and gemcitabine
WO2009058849A1 (en) 2007-10-29 2009-05-07 University Of Rochester Use of electrophilic compounds for inducing platelet production or maintaining platelet function
HUE043175T2 (hu) 2008-01-11 2019-08-28 Reata Pharmaceuticals Inc Szintetikus triterpenoidok és alkalmazásuk betegség kezelésében
ES2703274T3 (es) 2008-04-18 2019-03-07 Reata Pharmaceuticals Inc Moduladores de la inflamación antioxidantes: derivados del ácido oleanólico con modificaciones amino y otras en C-17
MX339476B (es) 2008-04-18 2016-05-27 Reata Pharmaceuticals Inc Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CN104250280A (zh) 2008-04-18 2014-12-31 里亚塔医药公司 抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物
KR101713140B1 (ko) 2008-04-18 2017-03-08 리타 파마슈티컬스 잉크. C-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체
EP2309860B1 (en) 2008-07-22 2014-01-08 Trustees of Dartmouth College Monocyclic cyanoenones and methods of use thereof
WO2010053817A1 (en) 2008-11-04 2010-05-14 Trustees Of Dartmouth College Betulinic acid derivatives and methods of use thereof
PL3254675T3 (pl) 2009-02-13 2019-09-30 Reata Pharmaceuticals, Inc. Kompozycje doustne o opóźnionym uwalnianiu, zawierające amorficzny cddo-me
SMT202000086T1 (it) 2010-04-12 2020-03-13 Reata Pharmaceuticals Inc Bardoxolone metile per il trattamento dell'obesità
US8618125B2 (en) 2011-01-14 2013-12-31 Heptiva LLC Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
JP6001560B2 (ja) 2011-01-31 2016-10-05 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Hiv成熟阻害活性を有するc−17およびc−3修飾トリテルペノイド
CA2829618C (en) 2011-03-11 2019-07-09 Reata Pharmaceuticals, Inc. C4-monomethyl triterpenoid derivatives and methods of use thereof
DK3444261T3 (da) 2012-04-27 2021-03-08 Reata Pharmaceuticals Inc 2,2-difluorpropionamidderivat af bardoxolonmethyl, farmaceutiske sammensætninger og polymorfer deraf til anvendelse ved behandling af visse lidelser
WO2013169740A2 (en) 2012-05-08 2013-11-14 Trustees Of Dartmouth College Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
CN103665087A (zh) 2012-09-03 2014-03-26 上海源力生物技术有限公司 一种萜类化合物及其在医药上的应用
PL2892912T3 (pl) 2012-09-10 2019-10-31 Reata Pharmaceuticals Inc C17-alkanodiylowe i alkenodiylowe pochodne kwasu oleanolowego i sposoby ich zastosowania
US9278912B2 (en) 2012-09-10 2016-03-08 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
MX2015003021A (es) 2012-09-10 2015-11-09 Abbvie Inc Derivados de acido glicirretinico y metodos de uso de los mismos.
HRP20171565T1 (hr) * 2012-09-10 2017-12-15 Reata Pharmaceuticals, Inc. C17-heteroaril derivati oleanolne kiseline i postupci njihove uporabe
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
TWI649330B (zh) 2013-04-24 2019-02-01 艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
NZ774222A (en) 2013-08-23 2023-01-27 Reata Pharmaceuticals Holdings Llc Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
WO2016033132A1 (en) 2014-08-26 2016-03-03 Trustees Of Dartmouth College Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
EA201890767A1 (ru) 2015-09-23 2019-09-30 Рита Фармасьютикалз, Инк. C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
AU2017356955B2 (en) 2016-11-08 2023-11-09 Reata Pharmaceuticals Holdings, LLC Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof
KR102891865B1 (ko) 2019-07-19 2025-11-26 리아타 파마슈티컬즈, 아이엔씨. C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법

Similar Documents

Publication Publication Date Title
JP2025524914A5 (enExample)
JP2023500611A5 (enExample)
JP2024119812A5 (enExample)
JP2022515197A5 (enExample)
JP2023531311A5 (enExample)
JP2023524598A5 (enExample)
JP2003515601A5 (enExample)
JP2002525329A5 (enExample)
JP6261011B2 (ja) 眼疾患処置薬
JP2019014758A5 (enExample)
JP2022522694A5 (enExample)
WO2009009501A4 (en) Non-basic melanin concentrating hormone receptor-1 antagonists and methods
RU97105381A (ru) Соединения и способы для лечения рака
JP2020122016A5 (enExample)
JP2022553954A5 (enExample)
JP2022137237A5 (enExample)
CN110248662A (zh) 一种治疗前列腺癌的组合、药物组合物及治疗方法
JP2024509981A5 (enExample)
JP2023544716A5 (enExample)
JP2021536510A5 (enExample)
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
CA2491612A1 (en) 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
JP2005538974A5 (enExample)
RU2003113538A (ru) Модифицированные пролекарственные формы ap/amp
JP2024540198A5 (enExample)